002737 葵花药业
已收盘 08-11 15:00:00
资讯
新帖
简况
葵花药业：截至2025年7月31日公司股东人数为5.94万人
证券之星 · 08-06
葵花药业：截至2025年7月31日公司股东人数为5.94万人
葵花药业最新公告：收到葵花牌益生菌粉和小葵花牌益生菌粉注册申请受理通知书
证券之星 · 07-31
葵花药业最新公告：收到葵花牌益生菌粉和小葵花牌益生菌粉注册申请受理通知书
保障用药安全，呵护健康生活 葵花药业荣获证券之星供应链影响力奖
证券之星 · 07-31
保障用药安全，呵护健康生活 葵花药业荣获证券之星供应链影响力奖
葵花药业最新公告：拟投资2000万元设立两家全资子公司
证券之星 · 07-25
葵花药业最新公告：拟投资2000万元设立两家全资子公司
葵花药业：截至2025年7月10日股东人数为5.6万人
证券之星 · 07-17
葵花药业：截至2025年7月10日股东人数为5.6万人
葵花药业去库存致净利预降超80% 销售费一年压缩9亿毛利率三连降
市场资讯 · 07-13
葵花药业去库存致净利预降超80% 销售费一年压缩9亿毛利率三连降
【葵花药业：上半年净利同比预降82.52%—85.61%】 葵花药业7月11日晚间披露业绩预告，公司预计2025年上半年实现归属于上市公司股东的净利润为7000万元—8500万元，同比下降82.52%—85.61%。报告期内，公司库存原材料成本处于高位，加之生产规模下降固定成本分摊增加、导致营业成本上升，进而对产品销售毛利率也产生较大影响。
金融界 · 07-11
【葵花药业：上半年净利同比预降82.52%—85.61%】 葵花药业7月11日晚间披露业绩预告，公司预计2025年上半年实现归属于上市公司股东的净利润为7000万元—8500万元，同比下降82.52%—85.61%。报告期内，公司库存原材料成本处于高位，加之生产规模下降固定成本分摊增加、导致营业成本上升，进而对产品销售毛利率也产生较大影响。
葵花药业：公司将合规推进权益分派事项
证券之星 · 07-08
葵花药业：公司将合规推进权益分派事项
医保概念盘中跳水，葵花药业跌0.13%
市场透视 · 06-19
医保概念盘中跳水，葵花药业跌0.13%
每周股票复盘：葵花药业（002737）股东户数增加800户，户均持股减少
证券之星 · 06-14
每周股票复盘：葵花药业（002737）股东户数增加800户，户均持股减少
葵花药业(002737)5月30日股东户数5.48万户，较上期增加1.48%
证券之星 · 06-10
葵花药业(002737)5月30日股东户数5.48万户，较上期增加1.48%
葵花药业：公司拥有药品批准文号千余个产品覆盖多个治疗领域
证券之星 · 06-04
葵花药业：公司拥有药品批准文号千余个产品覆盖多个治疗领域
葵花药业新提交“小葵花七七”等3件商标注册申请
证券之星 · 05-28
葵花药业新提交“小葵花七七”等3件商标注册申请
葵花药业：截至2025年5月9日，公司股东人数为5.4万人
证券之星 · 05-20
葵花药业：截至2025年5月9日，公司股东人数为5.4万人
葵花药业最新公告：控股孙公司双醋瑞因胶囊获得上市许可受理
证券之星 · 05-08
葵花药业最新公告：控股孙公司双醋瑞因胶囊获得上市许可受理
葵花药业(002737.SZ)：双醋瑞因胶囊获得上市许可受理
智通财经 · 05-08
葵花药业(002737.SZ)：双醋瑞因胶囊获得上市许可受理
葵花药业(002737)4月18日股东户数5.4万户，较上期减少1.96%
证券之星 · 05-07
葵花药业(002737)4月18日股东户数5.4万户，较上期减少1.96%
葵花药业：截至2025年4月18日，公司股东人数为5.4万人
证券之星 · 05-07
葵花药业：截至2025年4月18日，公司股东人数为5.4万人
【机构调研记录】诺德基金调研奥特维、葵花药业等6只个股（附名单）
证星机构调研 · 04-28
【机构调研记录】诺德基金调研奥特维、葵花药业等6只个股（附名单）
【私募调研记录】正圆投资调研葵花药业、青达环保等5只个股（附名单）
证星私募调研 · 04-28
【私募调研记录】正圆投资调研葵花药业、青达环保等5只个股（附名单）
加载更多
公司概况
公司名称：
葵花药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2014-12-30
主营业务：
葵花药业集团股份有限公司的主营业务是中成药、“化学药、生物药”和“健康养生品”的研发、制造与营销。公司的主要产品是护肝片、胃康灵胶囊、小儿肺热咳喘口服液、小儿化痰止咳颗粒、小儿氨酚黄那敏颗粒等。报告期内，公司荣登2024米思会（中国医药健康产业共生大会）-“2023 年度中国医药工业百强系列榜单”-“中国中药企业TOP100排行榜”-位列第1。
发行价格：
36.53
{"stockData":{"symbol":"002737","market":"SZ","secType":"STK","nameCN":"葵花药业","latestPrice":16.19,"timestamp":1754895807000,"preClose":16.12,"halted":0,"volume":6018471,"delay":0,"changeRate":0.0043,"floatShares":584000000,"shares":584000000,"eps":0.5034,"marketStatus":"已收盘","change":0.07,"latestTime":"08-11 15:00:00","open":16.12,"high":16.2,"low":16.06,"amount":97202400,"amplitude":0.0087,"askPrice":16.2,"askSize":1220,"bidPrice":16.19,"bidSize":270,"shortable":0,"etf":0,"ttmEps":0.5034,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1754962200000},"marketStatusCode":5,"adr":0,"adjPreClose":16.12,"symbolType":"stock","openAndCloseTimeList":[[1754875800000,1754883000000],[1754888400000,1754895600000]],"highLimit":17.73,"lowLimit":14.51,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":584000000,"isCdr":false,"pbRate":2.12,"roa":"--","peRate":32.161303,"roe":"1.3%","epsLYR":0.84,"committee":0.252756,"marketValue":9455000000,"turnoverRate":0.0103,"status":0,"floatMarketCap":9455000000},"requestUrl":"/m/hq/s/002737","defaultTab":"news","newsList":[{"id":"2557653344","title":"葵花药业：截至2025年7月31日公司股东人数为5.94万人","url":"https://stock-news.laohu8.com/highlight/detail?id=2557653344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557653344?lang=zh_cn&edition=full","pubTime":"2025-08-06 11:34","pubTimestamp":1754451260,"startTime":"0","endTime":"0","summary":"证券之星消息，葵花药业(002737)08月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2025年7月31日公司股东人数是多少？谢谢~葵花药业回复：截至2025年7月31日，公司股东人数为5.94万人。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080600015635.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002737","BK0028","BK0239"],"gpt_icon":0},{"id":"2555389007","title":"葵花药业最新公告：收到葵花牌益生菌粉和小葵花牌益生菌粉注册申请受理通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2555389007","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555389007?lang=zh_cn&edition=full","pubTime":"2025-07-31 16:22","pubTimestamp":1753950134,"startTime":"0","endTime":"0","summary":"葵花药业(002737.SZ)公告称，全资子公司哈尔滨葵花药业有限公司近日收到国家市场监督管理总局下发的关于葵花牌益生菌粉和小葵花牌益生菌粉注册申请的《受理通知书》。申报保健功能分别为有助于增强免疫力、有助于调节肠道菌群以及有助于增强免疫力。但需注意产品审评周期长、环节多，具体完成时间、审批结果存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073100025576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002737"],"gpt_icon":0},{"id":"2555000294","title":"保障用药安全，呵护健康生活 葵花药业荣获证券之星供应链影响力奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2555000294","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555000294?lang=zh_cn&edition=full","pubTime":"2025-07-31 16:05","pubTimestamp":1753949113,"startTime":"0","endTime":"0","summary":"近日，证券之星第三届ESG新标杆企业评选结果揭晓，葵花药业凭借在环境、社会和治理领域的卓越实践，荣获“供应链影响力奖”。在社会责任方面，葵花药业借助产业优势，携手小葵花儿童安全用药公益基金积极开展多项社会公益项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025073100024666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","BK0028","002737","BK0239"],"gpt_icon":0},{"id":"2554795883","title":"葵花药业最新公告：拟投资2000万元设立两家全资子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2554795883","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554795883?lang=zh_cn&edition=full","pubTime":"2025-07-25 22:36","pubTimestamp":1753454169,"startTime":"0","endTime":"0","summary":"葵花药业(002737.SZ)公告称，公司拟使用自有资金2000万元投资设立两家全资子公司，分别为葵花药业大健康科技吉安有限公司和葵花药业集团（哈尔滨）医药有限公司。此次投资旨在优化投资控股体系，实现营销体系各业务板块分线操作、独立运营，提升公司整体运营效率。投资不涉及关联交易，不构成重大资产重组，无需提交股东大会审议。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072500039154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002737","BK0028"],"gpt_icon":0},{"id":"2552217961","title":"葵花药业：截至2025年7月10日股东人数为5.6万人","url":"https://stock-news.laohu8.com/highlight/detail?id=2552217961","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552217961?lang=zh_cn&edition=full","pubTime":"2025-07-17 08:40","pubTimestamp":1752712824,"startTime":"0","endTime":"0","summary":"证券之星消息，葵花药业(002737)07月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司截止7月15日股东人数葵花药业回复：公司无法获取7月15日的股东信息，截至2025年7月10日，公司股东人数为5.6万人，感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071700005478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002737","BK0028"],"gpt_icon":0},{"id":"2551926485","title":"葵花药业去库存致净利预降超80% 销售费一年压缩9亿毛利率三连降","url":"https://stock-news.laohu8.com/highlight/detail?id=2551926485","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551926485?lang=zh_cn&edition=full","pubTime":"2025-07-14 06:58","pubTimestamp":1752447480,"startTime":"0","endTime":"0","summary":" “小葵花妈妈课堂开课了”这一耳熟能详的广告语，曾经让葵花药业成为知名品牌。 7月11日晚，葵花药业发布了业绩预告。 2024年上半年，葵花药业实现的归母净利润达4.86亿元，2023年上半年为6.38亿元。 对此，葵花药业解释称，主要是两个方面因素影响。 葵花药业的毛利率连续三年下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-07-14/doc-inffkshv6330176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","002737","BK0239"],"gpt_icon":0},{"id":"2550937579","title":"【葵花药业：上半年净利同比预降82.52%—85.61%】 葵花药业7月11日晚间披露业绩预告，公司预计2025年上半年实现归属于上市公司股东的净利润为7000万元—8500万元，同比下降82.52%—85.61%。报告期内，公司库存原材料成本处于高位，加之生产规模下降固定成本分摊增加、导致营业成本上升，进而对产品销售毛利率也产生较大影响。","url":"https://stock-news.laohu8.com/highlight/detail?id=2550937579","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550937579?lang=zh_cn&edition=full","pubTime":"2025-07-11 18:45","pubTimestamp":1752230740,"startTime":"0","endTime":"0","summary":"葵花药业7月11日晚间披露业绩预告，公司预计2025年上半年实现归属于上市公司股东的净利润为7000万元—8500万元，同比下降82.52%—85.61%。报告期内，公司库存原材料成本处于高位，加之生产规模下降固定成本分摊增加、导致营业成本上升，进而对产品销售毛利率也产生较大影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/11184551638892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["002737"],"gpt_icon":0},{"id":"2549130516","title":"葵花药业：公司将合规推进权益分派事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2549130516","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549130516?lang=zh_cn&edition=full","pubTime":"2025-07-08 16:12","pubTimestamp":1751962330,"startTime":"0","endTime":"0","summary":"证券之星消息，葵花药业(002737)07月08日在投资者关系平台上答复投资者关心的问题。投资者提问：2025年分红怎么还没有公布股权登记日，并且股票已经跌了这么多，管理层也没有采取什么措施，别的医药股这波行情都涨了很多，葵花药业却跌跌不休。葵花药业回复：公司将合规推进权益分派事项，具体时间安排请关注公司相关公告！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070800024824.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002737","BK0028","BK0239"],"gpt_icon":0},{"id":"2544131272","title":"医保概念盘中跳水，葵花药业跌0.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544131272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544131272?lang=zh_cn&edition=full","pubTime":"2025-06-19 13:03","pubTimestamp":1750309385,"startTime":"0","endTime":"0","summary":"06月19日，医保概念盘中跳水，截至13点03分，医保概念整体指数下跌2.02%，报1243.540点。从个股上来看，该概念的成分股中，葵花药业跌0.13%，江中药业跌幅居前。从资金上来看，截止发稿，医保概念主力净流入为-17.62亿，其中易明医药受到资金热捧，主力净流入5124.86万；拉长时间线来看，该板块近20日主力资金净流入-134.91亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619130305a4b1de35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619130305a4b1de35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600750","BK0188","BK0028","BK0239","002737","BK0175"],"gpt_icon":0},{"id":"2543593652","title":"每周股票复盘：葵花药业（002737）股东户数增加800户，户均持股减少","url":"https://stock-news.laohu8.com/highlight/detail?id=2543593652","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543593652?lang=zh_cn&edition=full","pubTime":"2025-06-14 11:09","pubTimestamp":1749870550,"startTime":"0","endTime":"0","summary":"截至2025年6月13日收盘，葵花药业报收于15.81元，较上周的15.73元上涨0.51%。本周，葵花药业6月13日盘中最高价报16.23元。葵花药业当前最新总市值92.33亿元，在中药板块市值排名26/68，在两市A股市值排名1692/5150。本周关注点股本股东变化：截至2025年5月30日葵花药业股东户数为5.48万户，较5月9日增加800.0户股本股东变化近日葵花药业披露，截至2025年5月30日公司股东户数为5.48万户，较5月9日增加800.0户，增幅为1.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061400011413.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002737","BK0028","BK0239"],"gpt_icon":0},{"id":"2542944973","title":"葵花药业(002737)5月30日股东户数5.48万户，较上期增加1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542944973","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542944973?lang=zh_cn&edition=full","pubTime":"2025-06-10 17:09","pubTimestamp":1749546562,"startTime":"0","endTime":"0","summary":"证券之星消息，近日葵花药业披露，截至2025年5月30日公司股东户数为5.48万户，较5月9日增加800.0户，增幅为1.48%。在中药行业个股中，葵花药业股东户数高于行业平均水平，截至5月30日，中药行业平均股东户数为5.31万户。从股价来看，2025年5月9日至2025年5月30日，葵花药业区间跌幅为1.44%，在此期间股东户数增加800.0户，增幅为1.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061000025932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002737","BK0239"],"gpt_icon":0},{"id":"2540703104","title":"葵花药业：公司拥有药品批准文号千余个产品覆盖多个治疗领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2540703104","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540703104?lang=zh_cn&edition=full","pubTime":"2025-06-04 15:12","pubTimestamp":1749021132,"startTime":"0","endTime":"0","summary":"证券之星消息，葵花药业(002737)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问：公司能否公布一下有哪些独家配方药品？国家保密配方，专利药品自己这种独家药品对公司营收的贡献比例？葵花药业回复：公司拥有药品批准文号千余个，产品覆盖“儿童用药、消化系统、呼吸感冒系统、风湿骨病系统、心脑血管系统、妇科、大健康”等治疗领域。其中，在销产品300个左右。独家品种/剂型28个。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060400017240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002737","BK0028","BK0239"],"gpt_icon":0},{"id":"2539840166","title":"葵花药业新提交“小葵花七七”等3件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2539840166","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539840166?lang=zh_cn&edition=full","pubTime":"2025-05-29 04:47","pubTimestamp":1748465244,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日葵花药业集团股份有限公司新提交“小葵花七七”等3件商标注册申请。商标申请详情如下：今年以来葵花药业集团股份有限公司新申请注册商标3件，截止目前公司共持有注册商标62件，另有3件商标尚在注册申请中。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052900002302.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002737","BK0028"],"gpt_icon":0},{"id":"2536651447","title":"葵花药业：截至2025年5月9日，公司股东人数为5.4万人","url":"https://stock-news.laohu8.com/highlight/detail?id=2536651447","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536651447?lang=zh_cn&edition=full","pubTime":"2025-05-20 08:51","pubTimestamp":1747702279,"startTime":"0","endTime":"0","summary":"证券之星消息，葵花药业(002737)05月19日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司董秘大人，截止5月10日股东人数有多少，非常感谢你，么么哒！！！葵花药业回复：截至2025年5月9日，公司股东人数为5.4万人，感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052000005428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002737","BK0239","BK0028"],"gpt_icon":0},{"id":"2533097121","title":"葵花药业最新公告：控股孙公司双醋瑞因胶囊获得上市许可受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2533097121","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533097121?lang=zh_cn&edition=full","pubTime":"2025-05-08 17:12","pubTimestamp":1746695527,"startTime":"0","endTime":"0","summary":"葵花药业(002737.SZ)公告称，控股孙公司葵花药业集团湖北武当有限公司于近日收到国家药品监督管理局下发的关于双醋瑞因胶囊申请注册上市许可的《受理通知书》。该产品拟定适应症为用于髋、膝关节的骨关节炎治疗。不过，药品审评周期长、环节多，具体完成时间、审批结果存在不确定性。公司将积极推进该产品的上市许可工作并持续关注审批情况，及时履行信息披露义务。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050800023968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002737","BK0239"],"gpt_icon":0},{"id":"2533975828","title":"葵花药业(002737.SZ)：双醋瑞因胶囊获得上市许可受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2533975828","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533975828?lang=zh_cn&edition=full","pubTime":"2025-05-08 16:32","pubTimestamp":1746693124,"startTime":"0","endTime":"0","summary":"智通财经APP讯，葵花药业(002737.SZ)发布公告，公司控股孙公司葵花药业集团湖北武当有限公司于近日收到国家药品监督管理局下发的关于双醋瑞因胶囊申请注册上市许可的《受理通知书》。上述药品在获国家药品监督管理局注册上市许可申请受理后，将转入国家药品监督管理局药品审评中心进行审评审批，鉴于药品审评周期长、环节多，期间可能受不确定性因素影响，具体完成时间、审批结果存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1290772.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"葵花药业(002737.SZ)：双醋瑞因胶囊获得上市许可受理","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002737","BK0028"],"gpt_icon":0},{"id":"2533672034","title":"葵花药业(002737)4月18日股东户数5.4万户，较上期减少1.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533672034","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533672034?lang=zh_cn&edition=full","pubTime":"2025-05-07 17:16","pubTimestamp":1746609374,"startTime":"0","endTime":"0","summary":"证券之星消息，近日葵花药业披露，截至2025年4月18日公司股东户数为5.4万户，较3月31日减少1081.0户，减幅为1.96%。在中药行业个股中，葵花药业股东户数高于行业平均水平，截至4月18日，中药行业平均股东户数为5.22万户。从股价来看，2025年3月31日至2025年4月18日，葵花药业区间跌幅为5.59%，在此期间股东户数减少1081.0户，减幅为1.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050700026168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002737"],"gpt_icon":0},{"id":"2533624265","title":"葵花药业：截至2025年4月18日，公司股东人数为5.4万人","url":"https://stock-news.laohu8.com/highlight/detail?id=2533624265","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533624265?lang=zh_cn&edition=full","pubTime":"2025-05-07 15:09","pubTimestamp":1746601758,"startTime":"0","endTime":"0","summary":"证券之星消息，葵花药业(002737)05月07日在投资者关系平台上答复投资者关心的问题。投资者提问：你好！请问截止到2025年04月20日止贵公司持股股东户数是多少？谢谢！葵花药业回复：截至2025年4月18日，公司股东人数为5.4万人，感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050700017575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002737","BK0028"],"gpt_icon":0},{"id":"2530146053","title":"【机构调研记录】诺德基金调研奥特维、葵花药业等6只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2530146053","media":"证星机构调研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530146053?lang=zh_cn&edition=full","pubTime":"2025-04-28 08:03","pubTimestamp":1745798594,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及4月25日披露的机构调研信息，诺德基金近期对6家上市公司进行了调研，相关名单如下：1）奥特维 个股亮点：公司目前应用于半导体封测环节的设备有划片机、铝线键合机、AOI检测设备等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504280814049747b995&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504280814049747b995&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","002737","688516","BK0251","BK0239"],"gpt_icon":0},{"id":"2530460533","title":"【私募调研记录】正圆投资调研葵花药业、青达环保等5只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2530460533","media":"证星私募调研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530460533?lang=zh_cn&edition=full","pubTime":"2025-04-28 08:00","pubTimestamp":1745798458,"startTime":"0","endTime":"0","summary":"5）当升科技 个股亮点：公司持有蓝谷智慧股权比例为2.54%，标的业务所涉及的电池回收及电池梯次利用等；公司是锂电池正极材料领域的龙头企业，其高镍三元材料广泛应用于新能源汽车动力电池。机构简介：深圳正圆投资2015年成立于深圳前海自贸区，并于当年获得私募证券投资基金牌照。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504280804449747b722&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504280804449747b722&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","688501","BK0239","002737","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1754900765706,"stockEarnings":[{"period":"1week","weight":-0.037},{"period":"1month","weight":0.052},{"period":"3month","weight":0.0409},{"period":"6month","weight":-0.0866},{"period":"1year","weight":-0.2787},{"period":"ytd","weight":-0.1882}],"compareEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.0877},{"period":"6month","weight":0.1003},{"period":"1year","weight":0.2666},{"period":"ytd","weight":0.0845}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"葵花药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"59400人(较上一季度增加6.07%)","perCapita":"9831股","listingDate":"2014-12-30","address":"黑龙江省哈尔滨市道里区高新技术产业开发区迎宾路集中区东湖路18号","registeredCapital":"58400万元","survey":" 葵花药业集团股份有限公司的主营业务是中成药、“化学药、生物药”和“健康养生品”的研发、制造与营销。公司的主要产品是护肝片、胃康灵胶囊、小儿肺热咳喘口服液、小儿化痰止咳颗粒、小儿氨酚黄那敏颗粒等。报告期内，公司荣登2024米思会（中国医药健康产业共生大会）-“2023 年度中国医药工业百强系列榜单”-“中国中药企业TOP100排行榜”-位列第1。","listedPrice":36.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"葵花药业(002737)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供葵花药业(002737)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"葵花药业,002737,葵花药业股票,葵花药业股票老虎,葵花药业股票老虎国际,葵花药业行情,葵花药业股票行情,葵花药业股价,葵花药业股市,葵花药业股票价格,葵花药业股票交易,葵花药业股票购买,葵花药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"葵花药业(002737)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供葵花药业(002737)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}